Bentham Science Publishers
Bentham Science Publishers is a major publisher of more than 100 peer-reviewed science, technology and medical (STM) journals, along with a rapidly growing collection of eBooks. Since 1993, Bentham Science Publishers has been catering to the information needs of the pharmaceutical, engineering, biomedical and medical research community.441 - 460 of 1750 results
-
-
Current Computer Science
Formerly Current Chinese Computer Science
Current Computer Science publishes original research articles, letters, reviews/mini-reviews, and guest-edited thematic issues dealing with various topics related to Computer Science.
Current Computer Science is not limited to a specific aspect of the field but is instead devoted to a wide range of sub-fields in the field. Articles of a multi-disciplinary nature are particularly welcome. Submissions in the following areas are of special interest to the readers of this journal:- Computer Engineering
- Theoretical Computer Science
- Machine Learning
- Communication and Security
- Telecommunications Engineering
- Artificial Intelligence
- Evolutionary Computing/Quantum Computing
- Relational Databases
- Software Engineering
- Computer Vision
-
-
-
Current Cosmetic Science
“Current Cosmetic Science” publishes original research articles, in-depth reviews/mini reviews, thematic issues, and technical notes covering all aspects of advancements in fundamental and applied research on skin, cosmetic and cosmeceutical products, isolation and comprehensive characterization of natural products and their synthesis to the beneficial effects of the constituents as cosmetic and cosmeceutical ingredients. The journal also explicitly welcomes interdisciplinary contributions considering wider social, cultural, ethical and applied aspects of cosmetic science in modern society.
General subject areas include but not limited to:- Cosmetic material research and characterization
- Cosmetic and Cosmeceutical formulation development
- Characterization and evaluations
- In vitro and in vivo safety in humans
- Efficacy of cosmetics and cosmeceuticals
- Toxicological studies in various animal models
- Topical products intended for Skin, nails and hair
- Analytical techniques involved in cosmetic and cosmeceutical product formulations and analysis
- Cosmetic Surgery and Dentistry
- Skin physiology and pharmacology
- Aesthetic and rejuvenation research
- Topical and transdermal testing
- Physical chemistry and technology of emulsion and dispersed systems, theory and application of surfactants
- Olfactory research
- Antioxidants
- Natural products
-
-
-
Current Dentistry
Current Dentistry, a peer-reviewed journal, publishes original research, expert reviews, and thematic issues in all areas of dental, oral and craniofacial sciences including biological, clinical, materials engineering and bioengineering aspects of dental research. The journal will be of interest to researchers in dental, oral, hard-tissue, and craniofacial science.
-
-
-
Current Developments in the Detection and Control of Multi Drug Resistance
The rise in the incidence of infections is caused by multi drug resistant (MDR) bacteria, it is essential to elucidate the basic mechanism of antibiotic resistance to discover effective methods for diagnosis and treatment of infections.
The use of pathogen-specific probes offers a faster alternative for pathogen detection and could improve the diagnosis of infection. High resolution melting analysis techniques are useful for the detection of multi drug resistant pathogens. Rational Structural Based Drug Design is a common method to identify a lead compound and take it forward for further developments.
This book provides information about recent strategies involved in the diagnosis and treatment of infections caused by MDR bacteria. The volume covers the use of molecular probes for the quantification of pathogenic bacteria, along with other techniques mentioned above.
Chapters also cover the use of identification of novel drug targets from the Lipid A biosynthesis and also from quorum sensing mediated biofilm formation in MDR bacteria. Chapters also cover herbal alternatives for the treatment of MDR bacteria like the use of Cassia aungustifolia in treatment of various diseases. The reference is suitable for biomedical students, cellular and molecular biologists.
-
-
-
Current Diabetes Reviews
Current Diabetes Reviews publishes full-length/mini-reviews, original research articles, drug clinical trial studies, and guest-edited issues on all the latest advances on diabetes and its related areas dedicated to clinical research, e.g., pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. It also includes topics related to diabetic complications such as retinopathy, neuropathy, nephropathy, renal failure and impotence, hypertension, gastrointestinal disorders, hearing impairment, hyperlipidemia, vascular and coronary heart diseases. Articles related to pancreatic islet dysfunction and insulin resistance, adipose tissue function, and glucose homeostasis are also covered. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.
-
-
-
Current Diagnosis of Infant Tuberculosis Infection
One of the most extraordinary characteristics of Mycobacterium tuberculosis infection is its capacity to remain within the host's tissues for a long period of time. There is an enormous reservoir of persons latently infected with tuberculosis (LTBI) estimated at about a third of the world's population. From this reservoir arise about 10 million new cases of active TB and more than two million deaths occur annually. Current Diagnosis of Infant Tuberculosis Infection covers problems concerning the diagnosis of LTBI, giving an overview of commercially available options and, unlike most reviews on this subject, also points out some tools currently under development. The Ebook provides comprehensive understandable, practice-oriented information on this subject, while keeping frontier research developments in consideration. It serves as an update to readers from universities to the research center and hospital staff - as well as a guide for helping clinicians to improve their diagnostic skills regarding TB infections in an endemic country (such as Brazil).
-
-
-
Current Drug Abuse Reviews
(Continued as Current Drug Research Reviews)
Current Drug Abuse Reviews aims to publish the highest quality reviews, meta-analyses and drug clinical trial studies on all latest advances on alcohol and drug abuse and addiction.
Book reviews are also published. The Journal will further comprise an agenda listing relevant meetings and conferences that will take place in near future, and advertisement.
-
-
-
Current Drug Delivery
Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.
The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.
The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
-
-
-
Current Drug Discovery Technologies
Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing original research papers, full-length/mini reviews, drug clinical trial studies and guest edited thematic issues describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.
Current Drug Discovery Technologies is an essential journal for all scientists and research managers involved in drug discovery who wish to keep abreast of all the modern techniques and technologies used in drug discovery.
-
-
-
Current Drug Metabolism
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:
In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.
-
-
-
Current Drug Research Reviews
(Formerly: Current Drug Abuse Reviews)
Current Drug Research Reviews publishes research articles, full-length/mini review articles and clinical studies on the design and development of new drugs, including drug targeting, medicinal chemistry, in-silico drug design, combinatorial chemistry, meta-analyses, drug abuse and addiction, drug-drug interactions and enzyme kinetics; species scaling and extrapolations; drug transporters; target organ toxicity and inter-individual variability in drug exposure-response; extrahepatic metabolism; bio-activation, reactive metabolites, high-throughput screening, drug targets and structure-activity relationships.
The journal aims to cover the latest developments in all important aspects of drug design, delivery, development and research.
Current Drug Research Reviews is essential for all pharmaceutical scientists involved in drug design and development.
-
-
-
Current Drug Safety
Current Drug Safety publishes frontier articles on all the latest advances in drug safety. The journal aims to publish the highest quality research articles, full-length/mini-reviews, and case reports in the field. Topics covered include adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. It also includes articles focused on resources for the identification of harmful substances and cellular, biochemical, and molecular mechanisms that are responsible for the side effects of drugs. The journal is essential reading for all researchers and clinicians involved in drug safety.
Current Drug Safety is an international, peer-reviewed journal on all aspects of drug safety, published quarterly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Targets
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
-
-
-
Current Drug Targets-CNS & Neurological Disorders
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.
-
-
-
Current Drug Therapy
Advances in Drug Discovery and General Therapeutics
Current Drug Therapy publishes high-quality original research articles, full-length/mini reviews, and guest-edited thematic issues covering a wide range of topics in drug science, therapy, and medical advancements. The journal encompasses research on:- Drug discovery, development, and delivery
- Clinical trials and real-world evidence studies
- Pharmacology, toxicology, and drug safety
- Targeted and biologic therapies, including immunotherapy
- Traditional, alternative, and regenerative medicine
- Personalized medicine, pharmacogenomics, and precision therapies
- Artificial intelligence and big data in drug research
- Regulatory science, drug approval processes, and public health perspectives
- Vaccine development, immunization strategies, and epidemiology
- Drug repurposing, repositioning, and novel therapeutic approaches
- Nanotechnology in Drug Delivery
- Gene and Cell Therapies
- Antimicrobial Resistance and Novel Antibiotics
- Neuropharmacology and Psychiatric Drug Development
- Pediatric and Geriatric Pharmacology
Current Drug Therapy is an international, peer-reviewed journal on all the latest advances in drug therapy and drug clinical trial studies, published monthly (print & online) by Bentham Science Publishers.
-
-
-
Current Engineering Letters and Reviews
Current Engineering Letters and Reviews publishes original letters (short articles), research articles, full-length/ mini-reviews and thematic issues based on mini-reviews and short articles dealing with various topics related to engineering sciences.
Original research letters, articles and reviews in the following areas of engineering sciences are of special interest to the readers of this journal:
● Aerospace engineering and technologies
● Agriculture and food engineering and technologies
● Bioengineering and biotechnologies, and bionic engineering and technologies
● Biomedical engineering and pharmaceutical engineering
● Chemistry and molecular engineering, and chemical engineering and technologies
● Civil, hydraulic, and architecture engineering
● Energetic materials, and explosion and propulsion technologies
● Energy sciences and technologies
● Engineering management
● Environmental sciences and engineering
● Information engineering and artificial intelligence technologies
● Light industries and textile engineering
● Materials sciences and engineering
● Mechanical engineering and automation technologies
● Mining engineering and metallurgical engineering
● Nanoscience and technologies
● Powder and electrical engineering
● Telecommunication engineering
● Transportation and vehicle engineering
● Sustainable and green engineering technologies
-